8-methoxy-2-n-butyramido-tetralin | 134865-71-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 四氢化萘
• 英文名称: 8-methoxy-2-n-butyramido-tetralin
• 英文别名: 8-methoxy-2-n-butyramidotetralin；N-(8-methoxy-1,2,3,4-tetrahydronaphthalen-2-yl)butanamide
• CAS: 134865-71-7
• 化学式: C₁₅H₂₁NO₂
• 分子量: 247.337
• InChiKey: IVNFMRONNXTTHN-UHFFFAOYSA-N

物化性质

• 沸点：
  456.7±45.0 °C(Predicted)
• 密度：
  1.07±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.8
• 重原子数：
  18
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.53
• 拓扑面积：
  38.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  8-methoxy-2-n-butyramido-tetralin 生成 N-((R)-8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-butyramide 、 N-((S)-8-Methoxy-1,2,3,4-tetrahydro-naphthalen-2-yl)-butyramide
  参考文献：
  名称：

  Selditz; Copinga; Grol, Pharmazie, 1999, vol. 54, # 3, p. 183 - 191

  摘要：

  DOI：
• 作为产物：
  描述：

  丁酸酐 以0.16 g (63%)的产率得到8-methoxy-2-n-butyramido-tetralin
  参考文献：
  名称：

  Substituted 2-amidotetralins as melatonin agonists and antagonists

  摘要：

  本发明通常涉及具有褪黑激素受体活性的化合物，特别是取代的2-酰胺四氢萘衍生物；包括这些化合物的制药制剂；以及将这些化合物用作治疗和诊断试剂的方法。

  公开号：

  US05071875A1

文献信息

• 2-Amido-8-methoxytetralins: A series of nonindolic melatonin-like agents
  作者：Swier Copinga、Pieter G. Tepper、Cor J. Grol、Alan S. Horn、Margarita L. Dubocovich

  DOI：10.1021/jm00072a008

  日期：1993.10

  A series of unsubstituted and methoxy-substituted 2-amidotetralins (4a-q) was prepared and evaluated for their ability to compete for 2-[I-125]iodomelatonin binding to chicken retinal membranes and for their potency to inhibit the calcium-dependent release of [H-3]dopamine from rabbit retina. The lead compound, 2-acetamido-8-methoxytetralin (4j), showed a moderate affinity (K(i) = 46 nM) and potency (IC50 = 1.4 nM) at the melatonin receptor. The structural requirements necessary for optimal agonistic activity at the melatonin receptor are as follows. First, the amido group, which should have a small, nonbranched alkyl group, is essential for affinity, and second, the methoxy substituent at the 8-position of the 2-amidotetralin ring is essential for optimal agonistic activity at the melatonin receptor. We concluded that this series of unsubstituted and methoxy-substituted 2-amidotetralins constitutes a class of nonindolic melatonin-like agents that can be used as pharmacological tools to further characterize melatonin receptors and to elucidate the mode of action of melatonin.
• METHODS OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR
  申请人：Chu Sainte-justine

  公开号：EP2120912A1

  公开（公告）日：2009-11-25
• METHOD OF CORRECTING IMBALANCE BETWEEN BONE RESORPTION AND BONE FORMATION AND KITS AND COMPOSITIONS THEREFOR
  申请人：Moreau Alain

  公开号：US20100029567A1

  公开（公告）日：2010-02-04

  Compounds, methods, uses, compositions, kits and packages for the treatment of imbalance between bone resorption and bone formation, based on uses of 4-phenyl-2 propionamidotetralin (4-P-PDOT) and analogs, derivatives, prodrugs, precursors thereof, and salts thereof, are described.
• US5071875A
  申请人：——

  公开号：US5071875A

  公开（公告）日：1991-12-10
• US5151446A
  申请人：——

  公开号：US5151446A

  公开（公告）日：1992-09-29